SEC Filing Summary: Form 8-K
Business Context and Reporting Period
Company: AspenBio Pharma, Inc. (Note: Request metadata referenced "Riot Platforms, Inc.", but the filing text identifies the registrant as AspenBio Pharma, Inc.)
Reporting Period: February 25, 2010
Location: Castle Rock, Colorado
Filing Type: Current Report (Form 8-K) under Section 13 or 15(d) of the Securities Exchange Act of 1934.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report serves as a disclosure notice rather than a financial statement.
Material Changes
No material financial changes or operational updates are detailed within the text of this filing. The document solely references the inclusion of a presentation.
Guidance, Outlook, and Management Commentary
- Regulation FD Disclosure (Item 7.01): The company incorporated by reference a PowerPoint presentation (Exhibit 99.1) dated February 2010, which contains company information.
- Availability: The presentation is available on the Company's website.
- Management Commentary: No direct commentary is provided in the text; details are contained within the referenced exhibit.
Investor Verification Checklist
- Verify the correct registrant name (AspenBio Pharma, Inc.) against the request metadata (Riot Platforms, Inc.).
- Access the Company's website to retrieve Exhibit 99.1 ("Power Point Presentation" dated February 2010) for actual financial data and strategic updates.
- Confirm the content of the presentation to understand the specific disclosure made under Regulation FD.